473545-40-3

Basic information

• Product Name: Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1-
• Synonyms: Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1-;tert-butyl [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]carbamate;(R)-Tert-Butyl (1,3-Dihydroxy-3-Methylbutan-2-Yl)Carbamate;tert-butyl(R)-(1,3-dihydroxy-3-methylbutan-2-yl)carbamate;(R)-Tert-Butyl (1,3-Dihydroxy-3-Methylbutan-2-Yl)Carbamate(WXC03802)
• CAS NO: 473545-40-3
• Molecular Formula: C₁₀H₂₁NO₄
• Molecular Weight: 219.27804
• Product Categories: N-BOC
• Mol File: 473545-40-3.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1-(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1-(473545-40-3)
• EPA Substance Registry System: Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1-(473545-40-3)

Safety Data

• Hazardous Substances Data: 473545-40-3(Hazardous Substances Data)

Usage

General Description

Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1- is a chemical compound with the molecular formula C6H13NO3. It is a carbamic acid derivative with a unique 1R configuration, containing a hydroxy group and a hydroxymethyl group attached to a 2-methylpropyl moiety. Carbamic acid, [(1R)-2-hydroxy-1-(hydroxymethyl)-2-methylpropyl]-, 1,1- is commonly used as a reagent and intermediate in organic synthesis and pharmaceutical manufacturing. It is also known for its potential applications in the field of medicinal chemistry and drug development. Additionally, carbamic acid derivatives have been studied for their biological activities and pharmacological properties, making them important targets for research and development in the pharmaceutical industry.

Upstream product

• 473452-22-1 methyl (S)-2-(tert-butoxycarbonylamino)-3-hydroxy-3-methylbutanoate 
• 864181-31-7 1-methyl-1-[(4R)-2-oxo-1,3-oxazolidin-4-yl]ethyl benzoate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 102507-13-1 N-(tert-butoxycarbonyl)-3-hydroxy-L-valine 
• 75-16-1 methylmagnesium bromide 
• 95715-85-8 2-(tert-butoxycarbonylamino)-3-hydroxypropionic acid methyl ester 
• 108149-60-6 methyl [(4R)-3-(tert-butoxycarbonyl)-2,2-dimethyl-1,3-oxazolidin-4-yl]carboxylate 
• 288159-36-4 tert-butyl (4R)-4-(1-hydroxy-1-methylethyl)-2,2-dimethyl-1,3-oxazolidine-3-carboxylate 
• 126181-46-2 (2R)-methyl 2-((tert-butoxycarbonyl)amino)-3-((tetrahydro-2H-pyran-2-yl)oxy)propanoate 
• 95715-86-9 (S)-2,2-dimethyl-oxazolidine-3,4-dicarboxylic acid 3-tert-butyl ester 4-methyl ester 
• 556-82-1 3-methyl-2-buten-1-ol 
• 116347-29-6 [(2S)-3,3-dimethyloxiran-2-yl]methanol 

Downstream Products

• 102507-13-1 N-(tert-butoxycarbonyl)-3-hydroxy-L-valine 
• 1275621-77-6 methyl (S)-2-(2,4-dinitrophenylsulfonamido)-3-hydroxy-3-methylbutanoate 
• 1275621-78-7 methyl (S)-1-(2,4-dinitrophenylsulfonyl)-3,3-dimethylaziridine-2-carboxylate 
• 1275621-80-1 benzhydryl (S)-2-(tert-butoxycarbonylamino)-3-hydroxy-3-methylbutanoate 
• 1275621-81-2 (S)-1-(benzhydryloxy)-3-hydroxy-3-methyl-1-oxobutan-2-aminium chloride 
• 1275621-82-3 benzhydryl (S)-2-(2,4-dinitrophenylsulfonamido)-3-hydroxy-3-methylbutanoate 
• 1275621-83-4 benzhydryl (S)-1-(2,4-dinitrophenylsulfonyl)-3,3-dimethylaziridine-2-carboxylate 
• 1275621-84-5 benzhydryl (S)-3,3-dimethylaziridine-2-carboxylate 
• 59979-01-0 thiocillin I 
• 2280-27-5 (S)-2-amino-3-hydroxy-3-methylbutanoic acid 
• 1217603-41-2 (S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-3-hydroxy-3-methylbutanoic acid 
• 123176-14-7 C₁₆H₃₆N⁽¹⁺⁾*C₁₀H₁₇N₂O₇S^(1-) 
• 102507-25-5 (3S)-3-[(t-Butyloxycarbonyl)amino]-4,4-dimethyl-1-(phenylmethoxy)-2-azetidinone 
• 102507-19-7 (S)-tert-butyl 1-(benzyloxyamino)-3-hydroxy-3-methyl-1-oxobutan-2-ylcarbamate 

Relevant articles and documents

MONOBACTAM COMPOUNDS AND USE THEREFOR

Monobactam compounds and a use therefor. Specifically provided are chemical compounds represented by formula (I) or isomers, pharmaceutically acceptable salts, solvates, crystals, or prodrugs thereof, preparation methods therefor, pharmaceutical compositions containing said compounds, and a use of said compounds or compositions in treating bacterial infection. The present compounds feature excellent antibacterial activity, and have great hopes of becoming a therapeutic agent for bacterial infection.

APPLICATION OF MONOCYCLIC BETA-LACTAM COMPOUND IN PHARMACY

An application of a compound represented by formula (I) and pharmaceutically acceptable salts thereof in preparation of a drug for treating pneumonia.

N-1 BRANCHED ALKYL ETHER SUBSTITUTED IMIDAZO[4,5-C]QUINOLINE COMPOUNDS, COMPOSITIONS, AND METHODS

Imidazo[4,5-c]quinoline compounds having a substituent that is attached at the N-1 position by a branched group, single enantiomers of the compounds, pharmaceutical compositions containing the compounds, and methods of making the compounds are disclosed. Methods of use of the compounds as immune response modifiers, for inducing cytokine biosynthesis in humans and animals, and in the treatment of diseases including infectious and neoplastic diseases are also disclosed.